David Stybr - NuGene International CEO Pres

All Insiders . USA . 
Stock . NuGene International . Stakeholders . Insider . David Stybr
NUGN Stock  USD 0  0  33.33%   

Insider

David Stybr is CEO Pres of NuGene International
Age 40
Phone980 432 8241
Webhttps://www.liventogroup.com

NuGene International Management Efficiency

The company has return on total asset (ROA) of (9.4427) % which means that it has lost $9.4427 on every $100 spent on assets. This is way below average. NuGene International's management efficiency ratios could be used to measure how well NuGene International manages its routine affairs as well as how well it operates its assets and liabilities.
NuGene International currently holds 2.8 M in liabilities with Debt to Equity (D/E) ratio of 1.05, which is about average as compared to similar companies. NuGene International has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist NuGene International until it has trouble settling it off, either with new capital or with free cash flow. So, NuGene International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NuGene International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NuGene to invest in growth at high rates of return. When we think about NuGene International's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Lieutenant CardonC3 Ai Inc
N/A
Shawn DilkesNukkleus
N/A
Houman BehzadiC3 Ai Inc
46
Patricia HouseC3 Ai Inc
66
Jim SnabeC3 Ai Inc
55
Lorenzo SimonelliC3 Ai Inc
47
Steve ColesC3 Ai Inc
N/A
Kira KimhiC3 Ai Inc
N/A
Julien GrouesC3 Ai Inc
N/A
Michael McCafferyC3 Ai Inc
67
Brady MickelsenC3 Ai Inc
49
Edward AbboC3 Ai Inc
60
Martin KleinC3 Ai Inc
N/A
Lisa DavisC3 Ai Inc
N/A
Jamal KhurshidNukkleus
47
Bruce SewellC3 Ai Inc
62
Mike McCafferyC3 Ai Inc
N/A
Bruce ClevelandC3 Ai Inc
61
Nehal RajC3 Ai Inc
41
Major KleinC3 Ai Inc
N/A
Livento Group, Inc. engages in the film and television production activities. Livento Group, Inc. was incorporated in 2013 and is based in New York, New York. Nugene International operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people. NuGene International [NUGN] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Return On Asset-9.44

NuGene International Leadership Team

Elected by the shareholders, the NuGene International's board of directors comprises two types of representatives: NuGene International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NuGene. The board's role is to monitor NuGene International's management team and ensure that shareholders' interests are well served. NuGene International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NuGene International's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Stybr, CEO Pres
John Ohanesian, Chief Hair
David Zich, Treasury Sec
Shahrokh Zekavati, Ex Manufacturing

NuGene Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is NuGene International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-9.44
Profit Margin(0.11) %
Operating Margin(0.11) %
Current Valuation14.83 M
Shares Outstanding219 M
Shares Owned By Insiders5.85 %
Price To Earning(0.03) X
Price To Sales9.65 X
Revenue1.47 M
Gross Profit(209.4 K)

Other Information on Investing in NuGene Pink Sheet

NuGene International financial ratios help investors to determine whether NuGene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGene with respect to the benefits of owning NuGene International security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY